![](/img/cover-not-exists.png)
Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme
Carla E. M. Hollak, Derralynn Hughes, Ivo N. van Schaik, Barbara Schwierin, Bruno BembiVolume:
18
Year:
2009
Language:
english
Pages:
8
DOI:
10.1002/pds.1779
File:
PDF, 96 KB
english, 2009